CLINICAL_TRIALS
trial_result
· 2023-01-26
Clinical Trial Update: Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer [Phase 2]
Summary
Phase 2 trial update assessing carboplatin with or without nivolumab in metastatic triple-negative breast cancer. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-01-26